Close Menu

reagents

The company will make and sell a Manchester-developed diagnostic reagent technology through an agreement that includes a research collaboration.

While revenues fell short of analysts' expectations for the quarter, the legacy Invitrogen business reported 7 percent organic revenue growth. The Q4 revenue numbers also do not include mass spec sales, which are now accounted for as an equity investment. In addition, company officials predicted 2009 organic revenue growth in the low single-digits.

Pages

Bloomberg Law writes that the Genetic Information Nondiscrimination Act may work better as a privacy, rather than anti-discrimination, law.

TechCrunch reports that Linda Avey has a new personal genomics startup that's focusing on India.

A new report finds that though the US has increased its activity in science and engineering, its global share of that activity has fallen in some areas, according to Inside Higher Ed.

In Nature this week: genomic analysis of rapeseed, universal target enrichment method for metagenomic sequencing, and more.